A registration trial to investigate ZILRETTA in shoulder osteoarthritis (OA)
Latest Information Update: 26 Jul 2022
At a glance
- Drugs Triamcinolone (Primary)
- Indications Osteoarthritis
- Focus Registrational; Therapeutic Use
- Sponsors Flexion Therapeutics
- 14 Jul 2022 According to a Pacira BioSciences media release, company is finalizing the design of this trial.
- 13 Aug 2021 New trial record
- 09 Aug 2021 According to a Flexion Therapeutics media release, this study is expected to be initiated later this year.